Author

Suh K. Stephen

DiagnoCine - Cited by 3,540 - Biomarkers for Precision Medicine - 3D HTP Culture Models - Biobanking - Animal Models - Informatics and Clinical Decision Support

Biography

Dr. Stephen Suh is presently serving as a Director of the Genomics and Biomarkers Program at Hackensack University Medical Center He completed his Ph.D. in Molecular and Cell Biology from the University of Texas Dallas Richardson TX He is presently a member of the American Association for Cancer Research AACR He is an Editorial Board member of several journals like Journal of Clinical Bioinformatics.
Title
Cited by
Year
Clinical decision support systems for improving diagnostic accuracy and achieving precision medicine
C Castaneda, K Nalley, C Mannion, P Bhattacharyya, P Blake, A Pecora, ...Journal of clinical bioinformatics 5 (1), 1-16, 2015201
365
2015
Molecular and clinical significance of fibroblast growth factor 2 (FGF2/bFGF) in malignancies of solid and hematological cancers for personalized therapies
MR Akl, P Nagpal, NM Ayoub, B Tai, SA Prabhu, CM Capac, M Gliksman, ...Oncotarget 7 (28), 44735, 2016201
160
2016
Protein calorie malnutrition, nutritional intervention and personalized cancer care
A Gangadharan, SE Choi, A Hassan, NM Ayoub, G Durante, S Balwani, ...Oncotarget 8 (14), 24009, 2017201
121
2017
Early detection biomarkers for ovarian cancer
S Sarojini, A Tamir, H Lim, S Li, S Zhang, A Goy, A Pecora, KS SuhJournal of oncology 2012, 2012201
114
2012
CLIC4 regulates TGF-β-dependent myofibroblast differentiation to produce a cancer stroma
A Shukla, R Edwards, Y Yang, A Hahn, K Folkers, J Ding, ...Oncogene 33 (7), 842-850, 201494201
94
2014
Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes
A Tamir, U Jag, S Sarojini, C Schindewolf, T Tanaka, R Gharbaran, ...Journal of ovarian research 7 (1), 1-15, 2014201
86
2014
Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicine.
MR Akl, P Nagpal, NM Ayoub, SA Prabhu, M Gliksman, B Tai, A Hatipoglu, ...Oncotarget, 2015201
75
2015
Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents
AA Inamdar, A Goy, NM Ayoub, C Attia, L Oton, V Taruvai, M Costales, ...Oncotarget 7 (30), 48692, 2016201
62
2016
High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphoma
PY Kuo, VV Leshchenko, MJ Fazzari, D Perumal, T Gellen, T He, J Iqbal, ...Oncogene 34 (10), 1231-1240, 2015201
61
2015
Blocking the adhesion cascade at the premetastatic niche for prevention of breast cancer metastasis
SA Kang, N Hasan, AP Mann, W Zheng, L Zhao, L Morris, W Zhu, ...Molecular Therapy 23 (6), 1044-1054, 2015201
59
2015
CLIC4 is a tumor suppressor for cutaneous squamous cell cancer
KS Suh, M Malik, A Shukla, A Ryscavage, L Wright, K Jividen, ...Carcinogenesis 33 (5), 986-995, 2012201
54
2012
The effect of soluble E-selectin on tumor progression and metastasis
S Kang, CA Blache, S Bajana, N Hasan, M Kamal, Y Morita, V Gupta, ...BMC cancer 16 (1), 1-13, 2016201
49
2016
Tissue banking, bioinformatics, and electronic medical records: the front-end requirements for personalized medicine
KS Suh, S Sarojini, M Youssif, K Nalley, N Milinovikj, F Elloumi, S Russell, ...Journal of oncology 2013, 2013201
49
2013
Pediatric Hodgkin lymphoma–biomarkers, drugs, and clinical trials for translational science and medicine
P Nagpal, MR Akl, NM Ayoub, T Tomiyama, T Cousins, B Tai, N Carroll, ...Oncotarget 7 (41), 67551, 2016201
40
2016
Potential biomarkers for predicting outcomes in CABG cardiothoracic surgeries
I Preeshagul, R Gharbaran, KH Jeong, A Abdel-Razek, LY Lee, E Elman, ...Journal of cardiothoracic surgery 8 (1), 1-12, 2013201
40
2013
The serine protease prostasin (PRSS8) is a potential biomarker for early detection of ovarian cancer
A Tamir, A Gangadharan, S Balwani, T Tanaka, U Patel, A Hassan, ...Journal of ovarian research 9 (1), 1-13, 2016201
33
2016
Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients
R Gharbaran, A Goy, T Tanaka, J Park, C Kim, N Hasan, S Vemulapalli, ...Journal of hematology & oncology 6, 1-17, 2013201
32
2013
The role of the ubiquitin proteasome system in lymphoma
KS Suh, T Tanaka, S Sarojini, G Nightingale, R Gharbaran, A Pecora, ...Critical reviews in oncology/hematology 87 (3), 6-322, 2013201
30
2013
E-selectin targeting PEGylated-thioaptamer prevents breast cancer metastases
Y Morita, M Kamal, SA Kang, R Zhang, GLR Lokesh, V Thiviyanathan, ...Molecular Therapy-Nucleic Acids 5, 2016201
27
2016
Safety evaluation of intravenously administered mono-thioated aptamer against E-selectin in mice
SA Kang, B Tsolmon, AP Mann, W Zheng, L Zhao, YD Zhao, DE Volk, ...Toxicology and applied pharmacology 287 (1), 86-92, 2015201
17
2015

Referred From: https://scholar.google.com/citations?user=jqV_SGQAAAAJ&hl=en

Cited by
Citations 3540
h-index 34
i10-index 48
Recommended Journals
Open Access Journals